Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 9876
Country/Region: Namibia
Year: 2016
Main Partner: Namibia Institute of Pathology
Main Partner Program: NA
Organizational Type: Parastatal
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Treatment: Adult Treatment (HTXS) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
LAB_PT CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 9
LAB_PT CD4: Number of laboratories that participate in this PT program 2017 20
LAB_PT CD4: Number of laboratories that perform this testing 2017 20
LAB_PT Early infant diagnostics: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT Early infant diagnostics: Number of laboratories that participate in this PT program 2017 1
LAB_PT Early infant diagnostics: Number of laboratories that perform this testing 2017 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 7
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 8
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 8
LAB_PT HIV viral load: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 2
LAB_PT HIV viral load: Number of laboratories that participate in this PT program 2017 2
LAB_PT HIV viral load: Number of laboratories that perform this testing 2017 8
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 27
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that participate in this PT program 2017 31
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that perform this testing 2017 31
LAB_PT TB diagnostics (Culture/DST): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT TB diagnostics (Culture/DST): Number of laboratories that participate in this PT program 2017 1
LAB_PT TB diagnostics (Culture/DST): Number of laboratories that perform this testing 2017 1
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 21
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that participate in this PT program 2017 22
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that perform this testing 2017 22